Depreciation of Cardiff Oncology, Inc. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Cardiff Oncology, Inc. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • Cardiff Oncology, Inc. Depreciation for the quarter ending 30 Sep 2025 was $89,000, a 12% decline year-over-year.
  • Cardiff Oncology, Inc. annual Depreciation for 2025 was $400,000, unchanged from 2024.
  • Cardiff Oncology, Inc. annual Depreciation for 2024 was $400,000, unchanged from 2023.
  • Cardiff Oncology, Inc. annual Depreciation for 2023 was $400,000, a 100% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Cardiff Oncology, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $400,000 $0 0% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 $400,000 $0 0% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 $400,000 +$200,000 +100% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $200,000 -$300,000 -60% 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
2021 $500,000 $0 0% 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
2020 $500,000 +$5,768 +1.2% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2022 2021 FY
2019 $494,232 -$241,856 -33% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2021 2020 FY
2018 $736,088 -$317,825 -30% 01 Jan 2018 31 Dec 2018 10-K 27 Feb 2020 2019 FY
2017 $1,053,913 +$84,080 +8.7% 01 Jan 2017 31 Dec 2017 10-K 06 Mar 2019 2018 FY
2016 $969,833 +$591,122 +156% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2018 2017 FY
2015 $378,711 +$143,898 +61% 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2017 2016 FY
2014 $234,813 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY

Cardiff Oncology, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $89,000 -$12,000 -12% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $94,000 -$11,000 -10% 01 Apr 2025 30 Jun 2025 10-Q 29 Jul 2025 2025 Q2
Q3 2024 $101,000 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $105,000 01 Apr 2024 30 Jun 2024 10-Q 29 Jul 2025 2025 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.